CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
4 research outputs found
The totality-of-the-evidence approach to the development and assessment of GP2015, a proposed etanercept biosimilar
Author
Afonso M
Afonso M
+12 more
Buffery D.
Feldman SR
Giampiero Girolomoni
Hilke Friccius-Quecke
Lovell DJ
Mark McCamish
Martin Schiestl
Mease PJ
Morrow T
Robert Ernst Mayer
Strober B
Vibeke Strand
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer
Author
Ayantunde
Baeuerle
+41 more
Balzar
Baumann
Becker
Berek
Burges
Carolyn N. Krasner
Cavazzoni
Davidson
Ferlay
Gotlieb
Heinzelmann-Schwarz
Heiss
Hilke Friccius-Quecke
Jager
Joan L. Walker
Jonathan S. Berek
Leslie R. DeMars
Lynn P. Parker
Maetzel
Michael W. Method
Passebosc-Faure
Patriarca
Pietzner
Robert P. Edwards
Robert T. Morris
Robert W. Holloway
Ruf
Samuel S. Lentz
Seimetz
Singh
Spizzo
Spizzo
Steven C. Plaxe
Strohlein
Thomas J. Herzog
Trzpis
Wallace L. Akerley
Went
Yoshida
Zeidler
Zeidler
Publication venue
'Ovid Technologies (Wolters Kluwer Health)'
Publication date
Field of study
No full text
Crossref
Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study
Author
A Marmé
AA Ayantunde
+40 more
Armando Santoro
B Davidson
C Patriarca
D Cella
D Seimetz
E Cavazzoni
Frederik Marmé
G Becker
G Spizzo
GL DeNardo
GL DeNardo
GR Mirick
H Woopen
Hilke Friccius-Quecke
Holger Martinius
I Azinovic
I Takeyoshi
Ignace Vergote
J Tamsma
Jalid Sehouli
K Passebosc-Faure
K Pietzner
Klaus Pietzner
M Chung
M Jäger
M Valle
MG Ott
MM Heiss
P Ruf
P Ruf
P Went
P Went
Per Rosenberg
R Zeidler
R Zeidler
RA Adam
Radoslav Chekerov
S Barni
S Cui
The EuroQol Group
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study
Author
A Burges
A Eramo
+49 more
A Walz
AA Ayantunde
Alexander S. Dudnichenko
Andreas Schneeweiss
Andrés Cervantes
Anneke Westermann
Armando Santoro
B Davidson
C Patriarca
Carsten Bokemeyer
Christoph Salat
Christophe Tournigand
D Maetzel
D Seimetz
Dominique Berton-Rigaud
E Cavazzoni
Florian Lordick
G Becker
G Spizzo
G Spizzo
Giovanni Scambia
H Woopen
Hilke Friccius-Quecke
Ignace Vergote
J Tamsma
Jalid Sehouli
JR Mackey
K Baumann
K Passebosc-Faure
Klaus Pietzner
L Ricci-Vitiani
M Jäger
M Valle
MM Heiss
Nicoletta Colombo
Olivier Trédan
P Ruf
P Ruf
P Went
P Went
P Wimberger
Pauline Wimberger
Per Rosenberg
R Riesenberg
R Zeidler
R Zeidler
RA Adam
S Barni
SL Parsons
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref